secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001213900-25-028646
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Executive Chairman Sapirstein resigns; Interim CFO Fedasz appointed Interim CEO
-------------------------------------------------------------------------------

- James Sapirstein resigned as Executive Chairman and Board member, effective March 28, 2025.
- Karina Fedasz, 52, previously Interim CFO, appointed Interim CEO effective April 2, 2025.
- Fedasz has background in finance, M&A, and capital raising; formerly CFO at IDW Media Holdings and Head of Business Development at Evofem Biosciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025028646/0001213900-25-028646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025028646/ea0237140-8k_oncon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-028646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer